comparemela.com
Home
Live Updates
Aulos Bioscience Advances AU-007 to Phase 2 Portion of Phase 1/2 Study Evaluating Computationally Designed IL-2 Antibody for Treatment of Solid Tumors : comparemela.com
Aulos Bioscience Advances AU-007 to Phase 2 Portion of Phase 1/2 Study Evaluating Computationally Designed IL-2 Antibody for Treatment of Solid Tumors
LARKSPUR, Calif.--(BUSINESS WIRE)--Dec 18, 2023--
Related Keywords
Australia ,
California ,
United States ,
Mike Beyer ,
Aron Knickerbocker ,
Sam Brown Inc ,
Society For Immunotherapy Of Cancer ,
Linkedin ,
Aulos Bioscience ,
These Phase ,
Annual Meeting ,
Biolojic Design ,
Apple Tree Partners ,
Sam Brown ,
Business Wire ,
Region ,
comparemela.com © 2020. All Rights Reserved.